These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7546822)

  • 1. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
    Horsman MR
    Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
    Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
    Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of agents counteracting hypoxia in fractionated radiation regimes.
    Stern S; Guichard M
    Radiother Oncol; 1996 Nov; 41(2):143-9. PubMed ID: 9004358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
    Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
    Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ; Horsman MR; Aoki DS
    Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.
    Horsman MR; Brown DM; Lemmon MJ; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1307-10. PubMed ID: 2944859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.
    McLaren DB; Pickles T; Thomson T; Olive PL
    Radiother Oncol; 1997 Nov; 45(2):175-82. PubMed ID: 9424009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamide.
    Brown JM; Lemmon MJ; Horsman MR; Lee WW
    Int J Radiat Biol; 1991 Mar; 59(3):739-48. PubMed ID: 1672362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW; Horsman MR; Chaplin DJ
    Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of tumor oxygenation by mild hyperthermia.
    Song CW; Park H; Griffin RJ
    Radiat Res; 2001 Apr; 155(4):515-28. PubMed ID: 11260653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of low dose nicotinamide versus benzamide, administered per os, as radiosensitizers in a C3H mammary carcinoma.
    Kjellen E; Pero RW; Nilsson P
    Radiother Oncol; 1988 Aug; 12(4):327-31. PubMed ID: 2973086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
    Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
    Bussink J; Kaanders JH; Van der Kogel AJ
    Acta Oncol; 1999; 38(7):875-82. PubMed ID: 10606417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
    Rojas A; Hirst VK; Calvert AS; Johns H
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
    Saunders M; Dische S
    Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.